A novel series of 2-(3-pyridyl)alkoxy-5-aryltetrahydrofuran PAF antago
nists has been identified and the effect of variation of the alkoxy ch
ain length, aryl substitution and stereochemistry about the tetrahydro
furan ring studied. The optimal compound, opanoxy)-5-(3,4,5-trimethoxy
phenyl)tetrahydrofuran (27a), inhibits [H-3]-PAF receptor binding to w
ashed human platelet membranes with an IC50 value of 100 nM.